'Therapeutics market competition' presentation slideshows

Scleroderma Diagnostics and Therapeutics Market Analysis, Growth Prospect and Applications till 2022

Scleroderma is also termed as systemic sclerosis (SSc), is a chronic, autoimmune disease characterized by structural and functional abnormalities of production of autoantibodies, small blood vessels, and fibrosis of the skin and internal organs. The diagnosis of scleroderma is based on the clinical appearances of the illness. Whereas, treatment is directed toward the individual features affecting different areas of the body.

99 views • 5 slides